Skip to main content

Table 3 Results of the univariate and multivariate regression analyses for the predictors of the no-reflow phenomenon

From: New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

Variables Unadjusted OR(95% CI) P value Adjusted OR(95% CI) P value
LVEF 0.95(0.92–0.98) 0.002 0.98(0.94–1.03) 0.428
Age 1.03(1.01–1.06) 0.005 0.991(0.953–1.03) 0.664
CK-MB 1.004(1.002–1.007) 0.001 1.007(1.003–1.012) 0.002
eGFR 0.982(0.971–0.993) 0.001 0.98(0.97–1.003) 0.093
Killip class 1.86(1.08–3.21) 0.025 0.101(0.02–0.54) 0.007
Stent length 1.01(0.998–1.02) 0.10 1.03(1.01–1.05) 0.012
Stent diameter 0.86(0.504–1.47) 0.581 0.87(0.38–2.04) 0.755
Multivessel disease 1.007(0.61–1.67) 0.979 0.014(0.003–0.08) < 0.001
Tirofiban infusion 1.53(0.94–2.51) 0.091 0.23(0.07–0.73) 0.012
CHA2DS2-VASc-HSF score 2.21(1.78–2.75) < 0.001 31.31(12.53–78.26) < 0.001
  1. Abbreviations: CK-MB creatine kinase-myocardial band, eGFR estimated glomerular filtration rate, OR odds ratio, LVEF left ventricular ejection fraction, CI confidence interval